Hospira has received an FDA warning citing 20 issues found at its facility in Rocky Mount, N.C., after a three-week inspection. The company, which develops infusion systems and injectable drugs, said it is cooperating with the FDA regarding the matter and will respond to the findings with a plan for remediation and modernization.
FDA warns Hospira over problems at N.C. plant
SmartBrief Job Listings for Health Care
|NGS Provider Enrollment Rep||
National Government Services - WellPoint
|Program Manager II||
Tufts Health Plan/Network Health
|Director, Medicare Advantage/Medicare Part D Focus||
|Chief, Product Review Branch||
FDA/Center for Biologics Evaluation and Research
|Silver Spring, MD|
|Director of Clinical Research||
Regenesis Biomedical, Inc.